Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.
Shiv Kumar Sarin, Ashish Kumar, Yogesh Kumar Chawla...
https://pubmed.ncbi.nlm.nih.gov/19669336/Actively Recruiting
Led by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Updated on 2026-10-29
400
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying Noncirrhotic Portal Hypertension NCPH, a condition caused by liver diseases that increase pressure in the livers blood vessels. NCPH often develops slowly without clear symptoms, and many people may be unaware they have it. This observational study aims to understand how NCPH progresses over time and to identify novel biomarkers to improve patient monitoring and management. Participants include people aged 12 and older who have NCPH or are at risk due to underlying diseases like cystic fibrosis, chronic granulomatous disease, or congenital hepatic fibrosis. The study involves initial screening visits with medical history, physical exams, urine and stool studies, ultrasounds, Fibroscan, blood tests, MRI, echocardiogram, and liver pressure measurements. Some participants may have liver biopsies. Follow-up visits occur every 6 months with regular exams and blood tests, and certain tests are repeated yearly or every few years depending on NCPH presence. Throughout the study, participants undergo various assessments to monitor liver health and disease progression, including upper endoscopy, esophagogastroduodenoscopy, and repeated liver biopsies for those with NCPH. Those without NCPH have periodic MRI and stool tests. Researchers collect data on bile acids, genetics, liver transcriptome, and microbiome signatures. The study is ongoing and may continue indefinitely, with regular monitoring to better understand NCPH development and progression.
CONDITIONS
Natural History of Noncirrhotic Portal Hypertension
J
Jaha F Norman-Wheeler
T
Theo Heller, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - Up to 2 visits over several weeks
Participants are screened to determine if they have or are at risk for Noncirrhotic Portal Hypertension. This includes medical history, physical exams, urine and stool studies, abdominal ultrasound, Fibroscan, blood tests, MRI, echocardiogram, liver pressure measurement, and possibly liver biopsy.
2 visits
Duration - Ongoing, indefinite duration
Participants attend clinic visits every 6 months for history, physical exams, and blood tests. Yearly and periodic tests such as ultrasounds, MRI, liver biopsies, endoscopies, and pressure measurements are done based on NCPH status to monitor disease progression.
Clinic visits every 6 months; additional tests yearly or every few years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Shiv Kumar Sarin, Ashish Kumar, Yogesh Kumar Chawla...
https://pubmed.ncbi.nlm.nih.gov/19669336/Jeoffrey N L Schouten, Juan C Garcia-Pagan, Dominique C Valla...
https://pubmed.ncbi.nlm.nih.gov/21574171/S K Sarin, S R Aggarwal
https://pubmed.ncbi.nlm.nih.gov/9693222/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Lead Sponsor